Affiliation:
1. V.A. Nasonova Research Institute of Rheumatology
Abstract
The results of gout therapy in many patients remain unsatisfactory, despite the availability of drugs and recommendations for its treatment. In addition to poor adherence to treatment by patients, medical errors and other reasons influence this situation. The article considers several clinical cases demonstrating the possibilities of a rational choice of urate-lowering therapy.
Subject
Pharmacology (medical),Immunology,Immunology and Allergy,Rheumatology
Reference51 articles.
1. Barskova VG, Nasonova VA. Modern definition of gout. Klinicheskaya gerontologiya. 2005;11(4):1-6. (In Russ.).
2. Punzi L, Scanu A, Galozzi P, et al. One year in review 2020: gout. Clin Exp Rheumatol. Sep-Oct 2020;38(5):807-21. Epub 2020 Oct 2.
3. Elfishawi MM, Zleik N, Kvrgic Z, et al. The Rising Incidence of Gout and the Increasing Burden of Comorbidities: A Populationbased Study over 20 Years. J Rheumatol. 2018 Apr;45(4):574-9. doi: 10.3899/jrheum.170806. Epub 2017 Dec 15.
4. Eliseev MS, Novikova AM. Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate-reducing therapy. Terapevticheskii arkhiv. 2019;91(5):120-8. (In Russ.).
5. Nasonov EL. Rossiiskie klinicheskie rekomendatsii. Revmatologiya [Russian clinical guidelines. Rheumatology]. Moscow: GEOTARMedia; 2017. P. 253-64.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献